Consolidated Portfolio Review Corp Nutri Band Inc. Transaction History
Consolidated Portfolio Review Corp
- $723 Billion
- Q2 2025
A detailed history of Consolidated Portfolio Review Corp transactions in Nutri Band Inc. stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 10,350 shares of NTRB stock, worth $84,973. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,350Holding current value
$84,973% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NTRB
# of Institutions
20Shares Held
352KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA199KShares$1.63 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA63.6KShares$521,7450.0% of portfolio
-
State Street Corp Boston, MA17.3KShares$141,7530.0% of portfolio
-
Haven Private, LLC Orlando, FL11.5KShares$94,5870.04% of portfolio
-
Northern Trust Corp Chicago, IL11.5KShares$94,2670.0% of portfolio
About NutriBand Inc.
- Ticker NTRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,803,260
- Market Cap $64.1M
- Description
- Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...